NOVEL IMMUNOTHERAPIES (CAR-T, BiTE)
Cardiovascular Risk Profile of Chimeric Antigen Receptor T-Cell Therapy
This review article explores the cardiotoxicity risk associated with CAR T-cell therapy in an effort to help clinicians choose the most appropriate patient population to undergo the novel therapy and understand the cardiac complications that may arise in the short or long term among these patients.
Cureus
